These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 32227754)

  • 1. Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease.
    Spertus JA; Jones PG; Maron DJ; Mark DB; O'Brien SM; Fleg JL; Reynolds HR; Stone GW; Sidhu MS; Chaitman BR; Chertow GM; Hochman JS; Bangalore S;
    N Engl J Med; 2020 Apr; 382(17):1619-1628. PubMed ID: 32227754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
    Spertus JA; Jones PG; Maron DJ; O'Brien SM; Reynolds HR; Rosenberg Y; Stone GW; Harrell FE; Boden WE; Weintraub WS; Baloch K; Mavromatis K; Diaz A; Gosselin G; Newman JD; Mavromichalis S; Alexander KP; Cohen DJ; Bangalore S; Hochman JS; Mark DB;
    N Engl J Med; 2020 Apr; 382(15):1408-1419. PubMed ID: 32227753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Coronary Disease in Patients with Advanced Kidney Disease.
    Bangalore S; Maron DJ; O'Brien SM; Fleg JL; Kretov EI; Briguori C; Kaul U; Reynolds HR; Mazurek T; Sidhu MS; Berger JS; Mathew RO; Bockeria O; Broderick S; Pracon R; Herzog CA; Huang Z; Stone GW; Boden WE; Newman JD; Ali ZA; Mark DB; Spertus JA; Alexander KP; Chaitman BR; Chertow GM; Hochman JS;
    N Engl J Med; 2020 Apr; 382(17):1608-1618. PubMed ID: 32227756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA.
    Mark DB; Spertus JA; Bigelow R; Anderson S; Daniels MR; Anstrom KJ; Baloch KN; Cohen DJ; Held C; Goodman SG; Bangalore S; Cyr D; Reynolds HR; Alexander KP; Rosenberg Y; Stone GW; Maron DJ; Hochman JS;
    Circulation; 2022 Apr; 145(17):1294-1307. PubMed ID: 35259918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design.
    Bangalore S; Maron DJ; Fleg JL; O'Brien SM; Herzog CA; Stone GW; Mark DB; Spertus JA; Alexander KP; Sidhu MS; Chertow GM; Boden WE; Hochman JS;
    Am Heart J; 2018 Nov; 205():42-52. PubMed ID: 30172098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial Invasive or Conservative Strategy for Stable Coronary Disease.
    Maron DJ; Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Boden WE; Chaitman BR; Senior R; López-Sendón J; Alexander KP; Lopes RD; Shaw LJ; Berger JS; Newman JD; Sidhu MS; Goodman SG; Ruzyllo W; Gosselin G; Maggioni AP; White HD; Bhargava B; Min JK; Mancini GBJ; Berman DS; Picard MH; Kwong RY; Ali ZA; Mark DB; Spertus JA; Krishnan MN; Elghamaz A; Moorthy N; Hueb WA; Demkow M; Mavromatis K; Bockeria O; Peteiro J; Miller TD; Szwed H; Doerr R; Keltai M; Selvanayagam JB; Steg PG; Held C; Kohsaka S; Mavromichalis S; Kirby R; Jeffries NO; Harrell FE; Rockhold FW; Broderick S; Ferguson TB; Williams DO; Harrington RA; Stone GW; Rosenberg Y;
    N Engl J Med; 2020 Apr; 382(15):1395-1407. PubMed ID: 32227755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical Therapy Versus Revascularization in Patients with Stable Ischemic Heart Disease and Advanced Chronic Kidney Disease.
    Paul TK; Mamas MA; Shanmugasundaram M; Nagarajarao HS; Ojha CP; Jneid H; Kumar G; White CJ
    Curr Cardiol Rep; 2021 Mar; 23(4):23. PubMed ID: 33655382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function.
    Bangalore S; Hochman JS; Stevens SR; Jones PG; Spertus JA; O'Brien SM; Reynolds HR; Boden WE; Fleg JL; Williams DO; Stone GW; Sidhu MS; Mathew RO; Chertow GM; Maron DJ
    JAMA Cardiol; 2022 Aug; 7(8):825-835. PubMed ID: 35767253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial).
    Sedlis SP; Jurkovitz CT; Hartigan PM; Kolm P; Goldfarb DS; Lorin JD; Dada M; Maron DJ; Spertus JA; Mancini GB; Teo KK; Boden WE; Weintraub WS;
    Am J Cardiol; 2013 Dec; 112(11):1703-8. PubMed ID: 24011740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA-CKD.
    Briguori C; Mathew RO; Huang Z; Mavromatis K; Hickson LJ; Lau WL; Mathew A; Mahajan S; Wheeler DC; Claes KJ; Chen G; Nolasco FEB; Stone GW; Fleg JL; Sidhu MS; Rockhold FW; Chertow GM; Hochman JS; Maron DJ; Bangalore S
    J Am Heart Assoc; 2022 Mar; 11(6):e022003. PubMed ID: 35261290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial.
    Nguyen DD; Spertus JA; Alexander KP; Newman JD; Dodson JA; Jones PG; Stevens SR; O'Brien SM; Gamma R; Perna GP; Garg P; Vitola JV; Chow BJW; Vertes A; White HD; Smanio PEP; Senior R; Held C; Li J; Boden WE; Mark DB; Reynolds HR; Bangalore S; Chan PS; Stone GW; Arnold SV; Maron DJ; Hochman JS;
    J Am Coll Cardiol; 2023 May; 81(17):1697-1709. PubMed ID: 37100486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
    Pracoń R; Spertus JA; Broderick S; Bangalore S; Rockhold FW; Ruzyllo W; Demchenko E; Nageh T; Grossman GB; Mavromatis K; Manjunath CN; Smanio PEP; Stone GW; Mancini GBJ; Boden WE; Newman JD; Reynolds HR; Hochman JS; Maron DJ;
    Circ Cardiovasc Interv; 2024 Jun; 17(6):e013435. PubMed ID: 38629312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes.
    Farkouh ME; Sidhu MS; Brooks MM; Vlachos H; Boden WE; Frye RL; Hartigan P; Siami FS; Bittner VA; Chaitman BR; Mancini GBJ; Fuster V
    J Am Coll Cardiol; 2019 Feb; 73(4):400-411. PubMed ID: 30704571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney Function Does Not Modify the Favorable Quality of Life Changes Associated With Revascularization for Coronary Artery Disease: Cohort Study.
    James MT; Wilton SB; Clement FM; Ghali WA; Knudtson ML; Tan Z; Tonelli M; Hemmelgarn BR; Norris CM;
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27436303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial.
    Herzog CA; Simegn MA; Xu Y; Costa SP; Mathew RO; El-Hajjar MC; Gulati S; Maldonado RA; Daugas E; Madero M; Fleg JL; Anthopolos R; Stone GW; Sidhu MS; Maron DJ; Hochman JS; Bangalore S
    J Am Coll Cardiol; 2021 Jul; 78(4):348-361. PubMed ID: 33989711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial.
    Reynolds HR; Shaw LJ; Min JK; Spertus JA; Chaitman BR; Berman DS; Picard MH; Kwong RY; Bairey-Merz CN; Cyr DD; Lopes RD; Lopez-Sendon JL; Held C; Szwed H; Senior R; Gosselin G; Nair RG; Elghamaz A; Bockeria O; Chen J; Chernyavskiy AM; Bhargava B; Newman JD; Hinic SB; Jaroch J; Hoye A; Berger J; Boden WE; O'Brien SM; Maron DJ; Hochman JS;
    JAMA Cardiol; 2020 Jul; 5(7):773-786. PubMed ID: 32227128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.
    Chaitman BR; Alexander KP; Cyr DD; Berger JS; Reynolds HR; Bangalore S; Boden WE; Lopes RD; Demkow M; Piero Perna G; Riezebos RK; McFalls EO; Banerjee S; Bagai A; Gosselin G; O'Brien SM; Rockhold FW; Waters DD; Thygesen KA; Stone GW; White HD; Maron DJ; Hochman JS;
    Circulation; 2021 Feb; 143(8):790-804. PubMed ID: 33267610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Medication Adherence With Health Outcomes in the ISCHEMIA Trial.
    Garcia RA; Spertus JA; Benton MC; Jones PG; Mark DB; Newman JD; Bangalore S; Boden WE; Stone GW; Reynolds HR; Hochman JS; Maron DJ;
    J Am Coll Cardiol; 2022 Aug; 80(8):755-765. PubMed ID: 35981820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial.
    Tegn N; Abdelnoor M; Aaberge L; Endresen K; Smith P; Aakhus S; Gjertsen E; Dahl-Hofseth O; Ranhoff AH; Gullestad L; Bendz B;
    Lancet; 2016 Mar; 387(10023):1057-1065. PubMed ID: 26794722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.